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ABSTRACT
Objectives: Because fibroblast filamentous actin (F-actin) influences cutaneous
interstitial matrix swelling pressure (5), we investigated whether F-actin in fi-
broblast-derived synoviocytes influences the hydraulic permeability of the trans-
synovial interstitial pathway. The study also tested whether F-actin in fenes-
trated synovial endothelium contributes to the blood-joint barrier in vivo.
Methods: The clearance of Evans blue-albumin (EVA) from plasma into the
knee joint cavity was determined in joint infused with F-actin disrupting cyto-
chalasin D (1–200 M), latrunculin B (100 M) or vehicle in anesthetized
rabbits. The hydraulic permeability of the lining was determined as the slope
relating net trans-synovial flow Q˙s to intra-articular pressure Pj. Synovium was
examined histologically after i.v. Monastral blue to assess endothelial leakiness.
Results: EVA permeation in vivo was increased up to 25-fold by cytochalasin (p
 0.0002, ANOVA), with an EC50 of 23 M (95% confidence limits 13–43
M). Washout quickly reversed the increase. Latrunculin had a similar effect.
F-actin disruption switched Q˙s from drainage (control) to filtration into the
cavity at low Pj in vivo and raised the conductance dQ˙s/dPj by 2.13 (p 0.001,
ANOVA). Circulatory arrest abolished these effects. Monastral blue revealed
numerous endothelial leaks.
Conclusions: F-actin is crucial to the barrier function of fenestrated endothe-
lium in situ. No significant effect of synoviocyte F-actin on matrix permeability
was detected.
Microcirculation (2002) 9, 419–430. doi:10.1038/sj.mn.7800149
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INTRODUCTION
Synovium is a sheet of vascular tissue that generates,
encapsulates, and drains the synovial fluid of joints.
The fluid is generated by a network of fenestrated
capillaries just below the synovial surface, which it-
self comprises a discontinuous layer of synoviocytes
and macrophages (14). The fenestrated endothelium
has a reflection coefficient of 0.78 for plasma al-
bumin (25), and a low-protein ultrafiltrate of
plasma trickles slowly into the joint cavity when sy-
novial fluid pressure is low, as in extended joints.
When synovial fluid pressure is raised by flexion, the
net trans-synovial inflow ceases, and intra-articular
fluid is driven out through drainage channels be-
tween the discontinuous lining cells into the subsy-
novial lymphatic system. The drainage pathway has
a high hydraulic resistance due to the presence of
hyaluronan, sulfated proteoglycans, fibronectin, and
collagens I, III, IV, V, and VI (32).
The hydraulic resistance of a matrix depends on its
hydration (6). Reed, Rubin, and colleagues have
shown that in rat skin and tracheal mucosa the ma-
trix hydration and interstitial fluid pressure are in-
fluenced actively by the filamentous actin (F-actin)
cytoskeleton of fibroblasts (5,43). F-actin is present
in synoviocytes and endothelium, linking the cells to
the extracellular matrix through 1 integrins (49)
and hyaluronan receptors (26,28). In addition, a pe-
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ripheral F-actin ring in endothelium serves as an
anchor for intercellular junctional proteins (12). In
light of the above facts, the work of Reed’s group
raised the issue of whether synovial F-actin might
influence fluid and macromolecular dynamics in
joints.
Specifically, the findings of Reed, Rubin, and col-
leagues indicated that fibroblast F-actin exerts ten-
sion on interstitial collagen through 21-integrins
and thereby opposes the interstitial glycosaminogly-
can swelling pressure. Disruption of the equilibrium
by antibody to 21-integrin or by the actin fila-
ment-disrupting agent cytochalasin caused intersti-
tial pressure to fall to a more subatmospheric pres-
sure during ∼30 minutes because of the unopposed
gel-swelling pressure. This was best demonstrated
post mortem. In vivo, interstitial pressure fell to a
lesser degree, and the hydration and albumin con-
tent of the tissue increased, indicating that F-actin
disruption raises endothelial permeability (5). Stud-
ies in vitro support this; in endothelial monolayers,
cytochalasin disrupts the microfilaments, raises per-
meability, and causes cell retraction and gap forma-
tion (1,19,22,46). Changes in F-actin distribution
also occur in venular endothelium during inflamma-
tion (3,15). Intravascular cytochalasin causes
edema, a fall in the albumin reflection coefficient,
and a rise in the microvascular filtration capacity in
vivo, (16,27,46).
The above findings raise two questions concerning
fluid transport in joints. First, does endothelial F-
actin influence the resistance of fenestrated endothe-
lium to fluid and macromolecule permeation? (The
above studies were conducted on continuous endo-
thelium.) Second, because synoviocytes are closely
related to fibroblasts (14) and have cytoskeletal
linkage to synovial extracellular matrix components
through integrins (45) and CD44 (2,20), does sy-
noviocyte F-actin influence extracellular hydration
and hence the permeability of the extracellular path-
way?
The above questions were addressed by experiments
using two F-actin-disrupting drugs, cytochalasin
and latrunculin. Cytochalasin D is a fungal metabo-
lite that disrupts the actin cytoskeleton in minutes,
primarily by capping the barbed or growing end of
the actin filament. The actin filament is a dynamic
structure that turns over at a rate of >4.5 m min−1
because of the continuous removal of monomeric G-
actin at one end and its addition at the opposite end
(48). Blockage of the growing end of the filament by
cytochalasin is quickly followed by filament disas-
sembly in endothelium (52) and fibroblasts (44).
Latrunculin B is a Red Sea sponge toxin that inhibits
F-actin polymerization by binding to the cytosolic
pool of G-actin, reducing its availability and causing
rapid filament disruption (11,47).
The present study examines the effects of F-actin-
disrupting agents on three parameters: the clearance
of labeled protein from plasma into the joint cavity;
Monastral blue permeation through endothelium;
and synovial matrix conductivity. The study extends
a recent investigation of changes in intra-articular
pressure and matrix interstitial pressure following
F-actin disruption (40). The latter investigation in-
dicated that actin disassembly raised capillary filtra-
tion rate and -globulin permeation, but that sy-
noviocyte F-actin disassembly had no detectable ef-
fect on interstitial fluid pressure post mortem, in
contrast to the findings of Berg et al. (5) in rat skin.
METHODS
Overview
Experiments were based on an established rabbit
knee model. After an i.v. injection of Evans blue-
tagged albumin (EVA) into the plasma compart-
ment, the joint cavity was cannulated and vehicle
with or without the F-actin-disrupting drug was in-
jected intra-articularly. After 30 minutes, the joint
fluid was sampled and a second intra-articular can-
nula was introduced. One cannula was connected to
a pressure transducer and the other to a raised fluid
reservoir and drop counter. The reservoir raised the
joint pressure Pj so that the relation between Pj and
net trans-synovial flow Q˙s could be determined. In-
tra-articular EVA was washed out every 15 minutes
to assess permeation across the blood-joint barrier.
The two key parameters studied were thus ClEVA
(clearance of Evans blue-albumin from synovial
plasma into joint cavity) and dQ˙s/dPj(the hydraulic
conductance of the synovial lining). In addition, en-
dothelial leakage was assessed histologically by the
Monastral blue method. The experiment was usually
repeated on the contralateral joint by using plain
vehicle or a low dose of drug.
Experimental Preparation and Determination
of dQ˙s/dPj
New Zealand white rabbits weighing 2.5–3 kg were
anesthetized with 30 mg kg−1 sodium pentobarbi-
tone plus 500 mg kg−1 urethane i.v. and tracheos-
tomized. Anesthesia was maintained at sufficient
depth to abolish the corneal blink reflex by using i.v.
15 mg of sodium pentobarbitone plus 250 mg of
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urethane every 30 minutes. Procedures conformed to
UK animal legislation, and animals were killed by an
overdose of i.v. sodium pentobarbitone at the end of
the experiment.
The intra-articular infusion and recording systems
were as described by Coleman et al. (10). A single
cannula was inserted initially into the joint cavity to
deliver a bolus of 150–400 L of test solution. After
30 minutes, the intra-articular fluid was aspirated
and a second intra-articular cannula was inserted
and connected to an infusion reservoir. The height of
the reservoir “clamped” Pj at any desired level. Flow
from the infusion reservoir into the joint cavity, Q˙in,
was recorded by a photoelectric drop counter. Be-
cause of the high cost of the drugs, only the terminal
10 mL of the infusion system was filled with drug-
containing solution. An inverted-U air gap separated
the test solution from the drop counter fluid. The
latter was a 0.1% v/v solution of chlorhexidine
(Hibitane; ICI, Macclesfield, UK), which reduced
surface tension to generate a drop of 6 L. A step
elevation of the infusion reservoir caused a transient
inrush of test fluid into the joint as the cavity ex-
panded and then Pj stabilized and flow reached a
steady state within 15 minutes (10,29).
Flows were measured at the end of each 15-minute
period at pressures of ∼2.5, 5.0, and 7.5 cmH2O
(below yield pressure) to estimate the physiological
conductance of the joint lining and then at ∼12, 16,
and 20 cmH2O (corresponding to taut effusions) to
estimate the raised conductances that develop above
the yield pressure of the synovial lining (13,29). Net
trans-synovial drainage rate Q˙s was calculated from
Q˙in at the end of each period by subtracting a small
correction for the viscoelastic creep of the cavity
walls as described previously (10,29).
With high concentrations of drug, the net trans-
synovial flow reversed direction at low intra-
articular pressures. Because a net trans-synovial
flow into the joint cavity halted the flow through the
drop counter, Q˙s was calculated as the rate of rise of
pressure dPj/dt multiplied by the corresponding
mean joint compliance, taken from Knight and
Levick (23).
Macromolecular Flux and Synovial Plasma
Clearance, ClEVA
A 10-mL injection of EVA was given through the ear
vein at the start of the experiment (10 mM of Evans
blue with 120 mg ml−1 bovine serum albumin in
Ringer’s solution). Dye is >99% bound in this mix-
ture because of its high-affinity coefficient (31).
Plasma samples were obtained by centrifugation of
venous blood taken at 30 minutes and the end, 270
minutes. At the end of the first 30 minutes of expo-
sure to drug and after each subsequent 15 minutes
infusion period, the intra-articular fluid was aspi-
rated and weighed. The EVA content of the aspirates
and plasma was determined densitometrically from
the light absorbance of 200 L samples in a multi-
well plate transilluminated by white light by using a
Fluor-S multi-imager and Quantity One Quantita-
tion Software (Biorad Laboratories Ltd., Hemel
Hempstead, UK) to analyze gray-scale images.
The flux of EVA from synovial plasma into the joint
cavity, dm/dt, was calculated as the cumulative sum
of all the aspirated EVA masses (concentration ×
aspirated volume) divided by time. A small correc-
tion was added for the unaspirated EVA mass in the
residual intra-articular fluid after the final aspira-
tion. Residual volume was estimated as the intra-
articular volume at the final pressure (taken from
the joint compliance curve) (32) minus the final as-
pirated volume. Small corrections were also added
for the trans-synovial convection of EVA out of the
joint cavity during each 15-minute interval between
aspirations; the washed-out mass was calculated as
Q˙s × 15 × mean intra-articular concentration (aver-
age of start and end concentrations). The above two
corrections were small and did not materially change
the result. Plasma clearance was calculated as (dm/
dt)/Cp, where Cp is mean plasma concentration dur-
ing the experiment. The plasma concentration fell by
∼5% per hour, so Cp was approximated as the arith-
metical average of the 30-minute and 270-minute
concentrations.
Demonstration of Endothelial Leakage Sites Using
Monastral Blue
The Monastral blue method (21) was used to test
whether cytochalasin D causes endothelial gap
formation in vivo. After an initial intra-articular
injection of cytochalasin D (100 M), dPj/dt was
monitored for 30 minutes to confirm that the drug
had taken effect. A volume of 2.5 mL of 3% par-
ticulate Monastral Blue BF suspension (copper
phthalocyanine, CI 74160) was then injected into
the ear vein, and cytochalasin D was infused con-
tinuously into the joint cavity at 5.6 cmH2O. After
1 hour, the animal was killed, and 6% paraformal-
dehyde solution was perfused through the joint
cavity for 30 minutes. The partially fixed joint lining
was excised, and control samples were taken from
the contralateral joint. Excised tissue was fixed
for 48 hours in paraformaldehyde and transferred
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to glycerine for 48 hours. Initial examination
through a dissecting microscope using epi-
illumination and low magnification indicated dye
leakage but had poor optical resolution. To improve
the optical conditions sheets of synovium were mi-
crodissected off the specimen, washed in Ringer’s
solution, dehydrated through a graded ethanol se-
ries, and clarified for 24 hours in methylsalicylate.
Clarified sheets were mounted en face for examina-
tion by transillumination by using a Zeiss micro-
scope at x80 to x320. Four sheets of synovium from
two rabbits were examined. In another two animals,
the synovial tissue was embedded in Spurr resin and
unstained, semi-thin sections (∼1 m thick) were cut
for light microscopy.
Intra-Articular Half-Life of Small,
Diffusible Solutes
The intra-articular concentration of a small, rapidly
diffusible solute such as cytochalasin D (508 Da)
decays continuously in vivo because of clearance by
the microcirculation. The intra-articular half-lives of
solutes of size 370–582 Da are 14–24 minutes (40).
Partly for this reason and partly to obtain samples,
the joint was aspirated as completely as possible ev-
ery 15 minutes and refilled with fresh solution. The
fall in intra-articular drug concentration was thus
limited to ∼1/2 nominal concentration before the
next top-up.
Materials
Cytochalasin D and latrunculin B were purchased
from Calbiochem (Nottingham, UK). Monastral
Blue, bovine serum albumin, dyes, phosphate-
buffered saline, and 2-macroglobulin (see below)
were from Sigma Chemical Co. (Poole, UK). Cyto-
chalasin D (1 mg) was dissolved in 0.5 mL of di-
methyl sulfoxide (DMSO), which was then added
drop by drop to phosphate-buffered saline at pH 7.4
with continuous rapid stirring to prevent precipita-
tion, until the required concentration was reached.
The control solutions, referred to as “vehicle,” con-
tained the same concentration of DMSO as the con-
tralateral test solution (maximum 5% DMSO).
Therefore, differences in response were attributable
to the drug, not DMSO. The infused drug concen-
trations were 0, 1, 10, 25, 50, 100, and 200 M of
cytochalasin D and 100 M of latrunculin B. DMSO
was not required to dissolve the latrunculin.
The broad-spectrum protease inhibitor 2-
macroglobulin was included in one experiment with
200 M of cytochalasin D to determine whether tis-
sue protease activation played a role (50). The
amount of 2-macroglobulin used, namely, 1 mg in
10 mL of 200 M of cytochalasin D, was sufficient
to inhibit >10 g of trypsin activity or 104 BAEE
units per mg protein.
Statistical Methods
Results were compared by using Student’s t test or
analysis of variance (ANOVA) as appropriate, with p
 0.05 considered a significant difference. To facili-
tate comparison of flows at identical pressures (be-
cause Pj varied a little between experiments), flows
were interpolated to standard pressures by linear in-
terpolation between the two bounding measure-
ments. Slopes were fitted to pressure-flow relations
by linear regression analysis. EC50 was estimated by
fitting a four-parameter logistic equation (top, bot-
tom, Hill slope, EC50; GraphPad Prism, San Diego,
CA) to the logarithmic dose-response curve. Means
and slopes are followed by their standard errors
throughout.
RESULTS
Permeation of EVA from Plasma into the
Joint Cavity
It was obvious from the washout color that the per-
meation of labeled plasma albumin into the joint was
increased greatly by cytochalasin D. Samples from
joint cavities infused with control solution were al-
most colorless, whereas samples from joints infused
with 25 M cytochalasin D were blue (dye con-
centration > 20 M). Even the first aspirate, after
only 30 minutes of exposure to drug, was blue, in-
dicating a rapid breakdown of the endothelial bar-
rier. The increased EVA permeation was maintained
throughout the 2-hour experiment.
In control joints the flux of EVA into the joint cavity
averaged 5.1 ± 1.8 nmol h−1 (n  8). Because the
plasma EVA concentration varied between rabbits,
the fluxes were normalized by plasma concentration
to calculate synovial plasma clearance (see Meth-
ods). The control clearance was 6.2 ± 1.4 L h−1
(n  8).
Cytochalasin D at 200 M, the highest concentration
investigated, increased the EVA flux approximately
25-fold to 126.3 ± 34.5 nmol h−1 and raised the
synovial plasma clearance to 167.0 ± 34.5 L h−1 (n
 4). Clearance increased as a sigmoidal function of
the logarithm of concentration as illustrated in Fig. 1
(p  0.0002, one-way ANOVA). All cytochalasin
concentrations of 50 M or above raised the clear-
ance significantly above control (p < 0.05, Bonfer-
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roni’s post hoc test). The estimated EC50 was 23 M,
with 95% confidence interval (CI) of 13–43 M.
Although cytochalasin is known to act directly on
endothelial cells (see Introduction), we also tested
whether protease activation might contribute to the
observed changes. Inclusion of the broad-spectrum
protease inhibitor 2-macroglobulin (see Methods)
had no discernible effect however. Cytochalasin D
with 2-macroglobulin raised the EVA clearance to
185 L h−1, which is ∼30 times the control value.
The effect of cytochalasin D on hydraulic conduc-
tance, described below, was likewise unaffected by
2-macroglobulin.
Fractional Extraction of Synovial Plasma EVA
The fractional extraction of albumin during the
transit of plasma through the synovial microcircula-
tion was estimated as the EVA clearance divided by
the synovial plasma flow, which was taken to be
45–90 L min−1 (40). The extraction of EVA across
normal synovial endothelium (mean clearance 6.2
L h−1, or 0.10 L min−1) was 0.1–0.2%. This is
similar to the extraction of radiolabeled albumin
from the human circulation (∼0.08%) (38). The low
extraction indicates that, despite its fenestrations,
synovial endothelium has only a low basal perme-
ability to plasma protein. This is in accord with its
high albumin reflection coefficient, 0.78 (25). The
extraction increased to 3.1–6.2% after treatment
with 200 M of cytochalasin.
Effect of Cytochalasin D on the Synovial
Pressure-Flow Relation In Vivo
The pressure-flow relation for saline across the nor-
mal synovial lining is usually approximated by two
straight lines, one fitted below 9 cmH2O (yield pres-
sure) and the other above it (13,29). Cytochalasin
treatment changed both the intercept and the slope
of the relation during the low-pressure range but had
no significant effect at higher pressures (Fig. 2).
Effect on Intercept. Cytochalasin D treatment re-
versed the direction of the net trans-synovial flow at
low pressures. The increased filtration into the joint
cavity shifted the intercept of the regression line with
the y-axis (net trans-synovial flow) at zero (atmo-
spheric) pressure in a negative direction. The shift
was −12.9 L min−1 in response to 100–200 M
cytochalasin D (n  6). The intercept shift was a
function of cytochalasin concentration (p < 0.001,
one-way ANOVA) and was statistically significant at
concentrations of 50 M (p < 0.05, Bonferroni’s
post hoc test). The sigmoidal relation between inter-
Figure 1. Permeation of Evans blue-labeled plasma al-
bumin into the joint cavity, expressed as plasma clear-
ance, as function of cytochalasin D concentration (mean ±
SEM). The result for vehicle alone is plotted at 10−1 M
cytochalasin on the logarithmic scale. The fitted curve
(EC50  23 M) is described in Statistical Methods.
Figure 2. Effect of 50–200 M cytochalasin D on relation
between net trans-synovial flow and joint fluid pressure.
Negative flows denote net filtration into the cavity. Open
circles, vehicle alone (n  8; mean ± SEM); the relation
steepens above ∼9 cmH2O (yield pressure) and is fitted by
two regression lines (see text). Filled circles, cytochalasin
D (n 6); at low intra-articular pressures cytochalasin D
reversed the flow and steepened the relation. Inset, effect
of 50 M of cytochalasin D in vivo and post mortem.
Circulatory arrest abrogates the effect of intra-articular
drug on trans-synovial flow and conductance.
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cept and the logarithm of concentration indicated an
EC50 of 25.7 M, with 95% CI of 16.3–40.6 M
(concentrations 0, 1, 10, 25, 50, 100, and 200 M,
corresponding n 8, 3, 2, 3, 4, 3, 3). Cytochalasin
had no significant effect on the intercept of regres-
sion lines fitted to results above yield pressure (p
0.65, one-way ANOVA).
Effect on Slope. Cytochalasin treatment increased
the slope dQ˙s/dPj during the low-pressure range, in-
dicating that the hydraulic permeability of the
endothelial and/or synovial interstitial pathway
had been raised (Fig. 2). The slope was a function of
the cytochalasin concentration (p  0.0014, one-
way ANOVA), and the sigmoidal relation between
the slope and the logarithm of concentration indi-
cated an EC50 of 17 M. The slope more than
doubled in response to 100–200 M cytochalasin,
from 0.87 ± 0.22 L min−1 cmH2O
−1 (control, n
8) to 1.86 ± 0.11 L min−1 cmH2O
−1 (n  6).
Cytochalasin did not increase the slope above yield
pressure (control, 2.33 ± 0.05 L min−1 cmH2O
−1,
n  8; cytochalasin-treated, 2.07 ± 0.09 L min−1
cmH2O
−1, n  6).
In control joints, dQ˙s/dPj increased 2.7-fold as pres-
sure was raised above yield point; the slope values
are given above. Because cytochalasin raised the
slope at low pressures (1.86 ± 0.11 L min−1
cmH2O
−1) but not at high pressures (2.07 ± 0.09 L
min−1 cmH2O
−1), there was no obvious yield point
after cytochalasin treatment.
To assess the contribution of microvascular filtration
to the above results, the pressure-flow relation in
vivo during cytochalasin infusion was compared with
that after cardiac arrest.
Effect of Cytochalasin D on Pressure-Flow Relation
After Circulatory Arrest
In vivo, treatment with 50 M of cytochalasin had
the following effects (Fig. 2, inset, lower relation).
The average trans-synovial flow at 2.5 cmH2O re-
versed direction from a net drainage of 1.39 ± 1.11
L min−1 (n 8, controls) to a net filtration of −5.6
± 1.0 L min−1 (n 4). The intercept shifted from
−1.1 ± 1.0 L min−1 (control) to −10.9 ± 2.4 L
min−1; the slope increased 2.3-fold, from 0.87 ±
0.22 L min−1 cmH2O
−1 (control) to 1.96 ± 0.34
L min−1 cmH2O
−1 (p < 0.05).
Circulatory arrest abolished the above responses
(Fig. 2, inset, upper relation). Measurements were
commenced immediately after the arrest. Circula-
tory arrest prevented the reversal of net trans-
synovial flow by cytochalasin; the trans-synovial
drainage rate at 2.5 cmH2O averaged +2.86 L
min−1 (n 2). The intercept, 0 ± 2.2 L min−1, was
no longer shifted to a negative value. The slope, 0.68
L min−1 cmH2O
−1, was no longer increased. These
results indicate that the effect of cytochalasin D on
trans-synovial flow depends on synovial microvas-
cular perfusion.
Correlation Between Changes in Albumin
Permeation and Trans-Synovial Flow
If cytochalasin acts by increasing the number and/or
size of gaps in the endothelial barrier (see later), a
correlation may be expected between macromolecule
permeation and filtration into the joint. Although the
protocol was not ideally suited for testing this issue,
there was a highly significant correlation between
filtration rate into the cavity at low pressure and
EVA clearance into the cavity at 0–200 M of cyto-
chalasin (Fig. 3) (Pearson’s r  0.72, p < 0.0001).
The dimensionless slope of the relation, −0.18 ±
0.03, indicates that the net filtration of 1 L into the
cavity was associated with the clearance of only
0.12–0.24 L (95% CI) of plasma EVA into the
cavity.
Figure 3. Correlation between the effect of cytochalasin
D on trans-synovial flow at low intra-articular pressure
and on the mean clearance of plasma Evans blue-albumin
into the same joint cavity during the course of the experi-
ment. Dimensionless slope of dashed regression line is
−0.18 ± 0.03 (n  28 joints).
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Reversibility of Cytochalasin-Induced
EVA Permeation
After the i.v. injection of EVA, the joint cavity was
infused with 50 M of cytochalasin D. The net trans-
synovial flow was measured at several intra-articular
pressures, and fluid was aspirated every 15 minutes
to assess EVA influx. The cavity was then washed
out three times with 500 L of Ringer’s solution,
and the flows and EVA fluxes were redetermined
with Ringer’s solution instead of cytochalasin D in
the infusion line. This protocol was followed in two
joints.
Figure 4 shows that the effect of cytochalasin on
plasma EVA permeation is readily reversed. The cy-
tochalasin D raised the EVA clearance to 196–350
L min−1 at 15–45 minutes. After washout and re-
infusion with Ringer’s solution, the EVA clearance
declined with time, falling to 54 L min−1 by 90
minutes after washout. A similar result was obtained
in the second joint.
The washout of the cytochalasin D also changed the
direction of net trans-synovial flow from, e.g., a net
filtration rate of −1.7 L min−1 at 5.5 cmH2O in the
presence of cytochalasin to a net drainage rate of
+3.7 L min−1 at 5.3 cmH2O after washout. Rapid
reversibility of the effect of cytochalasin D was like-
wise reported by Poli et al. (40).
Effects of Latrunculin B on Trans-Synovial Flow
and EVA Permeation
Two studies were conducted by using 100 M of
latrunculin B. The effects of latrunculin closely re-
sembled those of cytochalasin. The mean clearance
of EVA into the joint cavity increased by an order of
magnitude from 6 L min−1 (control) to 55 L
min−1 and 149 L min−1 (n  2). Net trans-
synovial flows at low pressure reversed direction
within 3.5–8.0 minutes to net filtrations into the
cavity of −2.5 L min–1 and −3.6 L min−1. The
intercept of the pressure-flow relation shifted nega-
tively to −4.3 L min−1 and −11.5 L min−1; slopes
dQ˙s/dPj in the low-pressure range increased to 1.10
L min−1 cmH2O
−1 and 1.31 L min−1 cmH2O
−1
(control 0.83 L min−1 cmH2O
−1). The similarity of
the effects of latrunculin and cytochalasin D, which
disrupt F-actin by different mechanisms, supports
the view that the observed changes are mediated
specifically through an effect on F-actin.
DMSO Controls
The similar responses to cytochalasin D solution and
latrunculin solution showed that the effects did not
depend on a synergism with DMSO; DMSO was not
present in the latrunculin solution. The pressure-
flow relation for control solutions containing DMSO
at 0.5–5.0% (0.77 ± 0.15 L min−1 cmH2O
−1) was
within the range for DMSO-free controls in a previ-
ous work (41). There was no significant relation be-
tween DMSO in the control solutions during the
range 0–5% and control dQ˙s/dPj (regression −0.04 ±
0.08 L min−1 cmH2O
−1 %−1, p 0.63, n 8) or
between % DMSO and control EVA clearance (re-
gression slope −0.05 ± 0.78 L h−1 %−1, p 0.95,
n  8). Thus, it is unlikely that DMSO influenced
the results.
Effect of Cytochalasin D on Monastral Blue Leakage
Through Endothelium
Intravenous Monastral blue did not label normal sy-
novial microvessels significantly. After cytochalasin
treatment, abundant spots and streaks of trapped
Monastral blue particles were seen in the synovial
sheets viewed en face (Fig. 5). The deposits were
distributed irregularly along the microvessels and
were often elongated, being up to 7–11 m long by
1–2 m wide. Streaks tended to run obliquely to the
longitudinal axis of the vessel and were occasionally
forked, which is consistent with the well-known
elongated, polyhedral arrangement of endothelial
cell margins. Semi-thin transverse sections showed
clusters of fine Monastral blue particles at the mar-
gins of microvessels. Where vessels were caught in a
grazing longitudinal section, rows of particles were
often observed, forming linear streaks similar to
those seen en face. Leakage was seen chiefly in mi-
crovessels of width 7–18 m, tentatively identified
Figure 4. Reversal of the effect of cytochalasin D on per-
meation of plasma EVA into the joint cavity after drug
washout.
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as postcapillary venules, but was also seen in capil-
laries as narrow as 5 m diameter.
DISCUSSION
The principal positive findings were that cytochala-
sin and latrunculin enhance fluid filtration into a
joint cavity and raise the plasma protein permeation
>10-fold. The EC50 values were larger than those
reported in vitro, but this may be due partly to the
short intra-articular half-lives of the drugs and
partly to phenotype changes in cultured endothe-
lium. The two main questions raised in the Intro-
duction are addressed below.
Does F-Actin Influence the Resistance of
Fenestrated Endothelium to Macromolecular and
Fluid Exchange In Vivo?
EVA fluxes are expressed here as clearances rather
than permeability because the latter term implies
purely diffusional transport, whereas both diffusion
and convection contributed to EVA transport in the
present study. The “apparent permeability” of the
blood-joint barrier, i.e., flux by combined diffusion-
convection/concentration difference, was only a few
percent higher than the reported plasma clearance
because the plasma concentration was more than an
order of magnitude higher than the intra-articular
concentration. The apparent permeability was in-
creased more than 20-fold by 200 M of cytochala-
sin D.
Because synovial endothelium is the site of reflection
of plasma proteins (25) and because the Monastral
blue experiments showed that leaks developed in the
endothelial layer, it seems reasonable to conclude the
increase in the apparent permeability of the blood-
joint pathway originated in the endothelial compo-
nent.
The correlation between increased albumin flux and
increased volume flux (Fig. 3) is attributed to endo-
thelial gap formation, which creates a new, shared
pathway for macromolecules and water. The high
filtration rate into the joint cavity is attributed to the
high conductance of endothelial gaps of m dimen-
sions, and presumably a large fall in the protein re-
flection coefficient . The latter would reduce the
effective plasma colloid osmotic pressure and thus
raise the net Starling filtration force. An increase in
net Starling filtration force is evident from the right
shift of the intercept with the x-axis (joint pressure
at zero net trans-synovial flow, Fig. 2); a right shift
is the expected effect of an increased net filtration
pressure due to a fall in  as indicated by a simpli-
fied, one-dimensional model of trans-synovial flow
(25,29). The changes, in fact, resemble those during
inflammation, in which endothelial intercellular and
transcellular gaps up to 1 m wide cause large in-
creases in microvascular filtration rate and plasma
protein leakage (35,37).
The slope of the relation in Fig. 3 shows that the
clearance of EVA into the joint cavity was substan-
tially less than the volume of fluid filtering into the
joint cavity per minute. Possible reasons include the
Figure 5. Photomicrographs of methylsalicylate-clarified
synovium viewed en face, showing endothelial leakage of
particulate intravascular Monastral blue after 100 M in-
tra-articular cytochalasin D in vivo (A and B) or no treat-
ment (C). A: Synovial venule with seven Monastral blue-
delineated leakage sites. Six of the sites are elongated
along the vessel longitudinal axis. Scale bar 45 m. B:
Venule with multiple leakage sites. Arrowed deposits are
elongated and branched. Scale bar  30 m. C: Un-
treated synovium from contralateral joint. No Monastral
blue deposits are present. Scale bar  50 m.
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non-zero reflection of albumin during filtration
through the drug-induced pathway, as in some his-
tamine-treated capillaries (9,36), and the loss of
pericapillary EVA into periarticular tissue, particu-
larly when the net trans-synovial flow was outward
at >45–60 minutes. Another possibility would be the
formation of high conductance but reflective path-
ways, such as the fenestrations induced by the cal-
cium ionophore A23187 in mesenteric capillaries
(8).
Relation Between Filamentous Actin and
Endothelial Barrier Integrity
As reviewed in the Introduction, cytochalasin in vitro
causes the breakdown of actin microfilaments, inter-
cellular gap formation, and cell retraction in conflu-
ent endothelial cultures. In the present study, endo-
thelial gaps formed in vessels in situ, indicating that
actin filaments contribute to the structural integrity
of the fenestrated endothelial barrier. This conclu-
sion is in keeping with the view that intercellular
junction proteins, such as the cadherin-catenin com-
plex, are restrained spatially by linkage through
-actinin to the actin cytoskeleton (12). Other cell
lines with a similar junctional biochemistry show a
reduction in the number of junctional strands after
cytochalasin treatment (4,34,42). Our observations
do not exclude the formation of transcellular gaps, as
opposed to intercellular gaps (37), or the involve-
ment of vesicular-vacuolar organelles (17).
It is possible, in principle, that the cytochalasin D
might act indirectly, e.g., to trigger mast cell de-
granulation. This seems unlikely to be the major
mechanism, however, because cytochalasin D has a
powerful, direct effect on isolated endothelium.
Moreover, the microvascular hyperpermeability was
well maintained for >2 hours, whereas the effect of
mast cell histamine peaks early (10–20 minutes) and
decays rapidly.
Rapidity of Drug Action and Reversal
The rapid effect of cytochalasin on EVA permeation
(Fig. 4) indicates a fast turnover of F-actin in fenes-
trated endothelium in vivo, in keeping with the fast
turnover of F-actin in many cultured cell lines (48).
Cytochalasin in vitro can increase the permeability
of arterial endothelial monolayers to dextran by
fourfold in 30 minutes (22). The reversal of the hy-
perpermeability state within minutes of drug wash-
out (Fig. 4) indicates a rapid rebuilding of F-actin
within the fenestrated endothelial cell in vivo.
Potential Relation Between F-Actin Disruption and
Synovial Inflammation
The combination of order-of-magnitude increases in
plasma protein permeation, rapid fluid filtration,
and endothelial gap formation reported here closely
resembles the acute response to proinflammatory
agonists such as histamine, serotonin, bradykinin,
and interleukin IL-1. Histamine, serotonin, and
bradykinin quickly cause plasma extravasation into
the rat knee joint (7,39). Interleukin IL-1 causes
large increases in trans-synovial fluid filtration,
raised intra-articular pressure, and increased albu-
min permeation in the equine metacarpophalangeal
joint (18). In human synovitis, a breakdown of the
endothelial barrier to plasma proteins and water
leads to the accumulation of a protein-rich joint ef-
fusion (51).
In view of the similarities, it is tempting to suggest
that F-actin disruption may be one of the links be-
tween agonist receptor activation and gap formation.
In support of this, changes in F-actin distribution
and disruption of the peripheral F-actin ring are ob-
served in endothelium in response to proinflamma-
tory agonists (3,15,33). By contrast, a popular para-
digm for gap formation invokes endothelial contrac-
tion through a sliding filament mechanism
dependent on the interaction of actin filaments with
phosphorylated myosin, a process that seems un-
likely to be enhanced by the disruption of F-actin.
The possibility that endothelium contains a stable,
myosin-associated pool of F-actin and a rapidly
turning over, cytochalasin-sensitive pool of cytoskel-
etal F-actin linked to the junctional proteins would
be one possible solution to this paradox.
Does Synoviocyte F-Actin Influence the
Permeability of the Extracellular Pathway?
The other question raised in the Introduction was
whether the F-actin cytoskeleton of synoviocytes in-
fluences the permeability of the joint lining, through
an effect on matrix swelling tendency and hydration
analogous to that observed by Berg et al. (5) in rat
skin. A partial answer to this question was provided
by Poli et al. (40), who found that cytochalasin has
no detectable effect on interstitial fluid pressure in
the synovial lining. Two findings here reinforce the
conclusion that synoviocyte F-actin does not acutely
influence the interstitial matrix properties. First, cy-
tochalasin D did not affect hydraulic conductance
dQ˙s/dPj above yield pressure. In this pressure range,
the net flow is predominantly interstitial, because
interstitial permeability increases above yield pres-
sure (13,30,41). Second, when endothelial fluid
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exchange was eliminated by circulatory arrest, cyto-
chalasin likewise failed to raise the hydraulic con-
ductance dQ˙s/dPj at low pressures (Fig. 2, inset).
Thus, the results indicate that cytochalasin D does
not increase the conductance of the synovial inter-
stitial pathway either below or above yield pressure.
A potential alternative interpretation of the observa-
tions post mortem would be that circulatory arrest
itself reduces the interstitial matrix conductance
within 15 minutes or so. However, a recent servo-
null micropipette study showed that the interstitial
pressure profile across the joint lining for a given
trans-synovial flow post mortem is indistinguishable
from that in vivo (45b). This finding indicates that
circulatory arrest does not alter the matrix conduc-
tance.
In joints with a functionally intact microcirculation,
the increase in dQ˙s/dPj induced by cytochalasin is
attributed to the reduced resistance of the endothe-
lial component of the series pathway; endothelial re-
sistance is a substantial component, ∼50%, of the
total resistance to flow between blood and the joint
cavity at low intra-articular pressure (24).
In control synovium, the slope dQ˙s/dPj increased
nearly threefold above ∼9 cmH2O, producing a kink
in the pressure-flow plot. This long-recognized phe-
nomenon is caused by increased stretch and hydra-
tion of the interstitial matrix (13,30,41). After cyto-
chalasin treatment, the slope at low pressure, 1.86 ±
0.11 L min−1 cmH2O
−1, had increased to a value
almost as big as that at high pressures, 2.07 ± 0.09
L min−1 cmH2O
−1, so a kink in the curve was no
longer detectable.
To summarize, the results showed that F-actin in the
fenestrated synovial endothelium has a major role in
maintaining the normal synovial microvascular bar-
rier to plasma albumin and fluid filtration. The re-
sults failed to support the hypothesis that the F-actin
in synoviocytes influences the permeability of the
synovial interstitial pathway.
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